Market Place
Sourcing Support
PharmAbcine Announces Safety Approval For PMC-403 Trial
14 Oct 2024 //
PR NEWSWIRE
PharmAbcine`s PMC-403 Trial For Macular Degeneration Advances
02 Jul 2024 //
PR NEWSWIRE
PharmAbcine`s Wincal Presenting Ocular Data At ARVO 2024
22 Apr 2024 //
PR NEWSWIRE
PharmAbcine Publishes Study in Advances Demonstrating the Potential of PMC-403
22 Nov 2023 //
PR NEWSWIRE
PharmAbcine Receives Approval to Advance to Dose Level 2 of Trial of PMC-403
09 Nov 2023 //
PR NEWSWIRE
PharmAbcine Receives IND Approval from Korean MFDS forTIE2 Agonistic Antibody
23 May 2023 //
PR NEWSWIRE
PharmAbcine to participate in "BIO International Convention 2023"
08 May 2023 //
PR NEWSWIRE
PharmAbcine Announces Collaboration Agreement with MSD to Evaluate PMC-309
12 Dec 2022 //
PRNEWSWIRE
PharmAbcine to Participate in BIO-Europe 2022
26 Sep 2022 //
PRNEWSWIRE
PharmAbcine announces positive results for its novel TIE2-activating antibody
28 Apr 2022 //
BIOSPECTRUMASIA
PharmAbcine Presents Updated Preclinical Data of Anti-VISTA Antibody Candidate
11 Apr 2022 //
PRNEWSWIRE
RNAGENE Signs Collaborative Agreement with PharmAbcine for mRNA Therapeutics
21 Mar 2022 //
PRNEWSWIRE
South Korea lays focus on novel mRNA therapeutics
15 Mar 2022 //
BIOSPECTRUMASIA
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody
19 Oct 2021 //
BIOSPACE
PharmAbcine Gets HREC Clearance for Phase II Trial of 2 Products in mTNBC
03 Sep 2021 //
PRNEWSWIRE
PharmAbcine Gets HREC Clearance for Phase II Trial of 2 Products in mTNBC
03 Sep 2021 //
PRNEWSWIRE
PharmAbcine to Participate in Biotechgate Digital Partnering
17 Aug 2021 //
PRNEWSWIRE
PharmAbcine Announces Encouraging Non-clinical Data of PMC-403
10 May 2021 //
PRNASIA
PharmAbcine Announces Encouraging Non-clinical Data of PMC-403
10 May 2021 //
PRNEWSWIRE
PharmAbcine to Present at the Association for Research in Vision (ARVO)
26 Apr 2021 //
PRNASIA
PharmAbcine to Present at the Association for Research in Vision and (ARVO)
26 Apr 2021 //
PRNEWSWIRE
PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II
19 Apr 2021 //
PRNASIA
PharmAbcine announces Clinical Trial Collaboration with MSD
19 Apr 2021 //
PRNEWSWIRE
PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021
13 Apr 2021 //
PRNASA
PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021
13 Apr 2021 //
PRNESWIRE
PharmAbcine announces a research collaboration with LegoChem Biosciences
11 Jan 2021 //
PRNASIA
PharmAbcine to participate in BIO @ JPM and Biotech Showcase Digital during
04 Jan 2021 //
PRNEWSWIRE
PharmAbcine to participate in BIO @ JPM and Biotech Showcase
04 Jan 2021 //
PRNASIA
PharmAbcine presents the latest data of the ongoing Phase Ib mTNBC trial
09 Dec 2020 //
PRNASIA
PharmAbcine to present new interim data from its mTNBC trial at SABCS 2020
07 Dec 2020 //
PRNASIA
PharmAbcine to present new interim data from its ongoing mTNBC trial
07 Dec 2020 //
PRNEWSWIRE
PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020
16 Nov 2020 //
PRNASIA
PharmAbcine expands partnership with Samsung Biologics for PMC-403
21 Sep 2020 //
BIOSPACE
PharmAbcine Unveils Olinvacimab`s Positive Results from Combination Studies
14 Sep 2020 //
PRNEWSWIRE
PharmAbcine is presenting at the KSMO 2020
02 Sep 2020 //
PRNNEWSWIRE
Binex can produce olinvacimab at its new 5,000L production line
02 Sep 2020 //
PRNASIA
PharmAbcine announces the execution of a Material R&D (MCRADA) with the NIH
18 Aug 2020 //
PRNEWSWIRE
PharmAbcine Collaborates with Wuxi Shuangliang Biotechnology
12 Aug 2020 //
CONTRACTPHARMA
PharmAbcine signs a research collaboration agreement with Wuxi (SLBio)
03 Aug 2020 //
PRNEWSWIRE
